“The present predicament has uncovered some structural weaknesses in the EU’s medicines source chain and a high dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides said. She advisable that provide chain issues be addressed within an EU pharmaceutical tactic expected to get launched by the end of the 12 months.The U